Sign in
CGON Stock Price, Chart, Stats & News
CG Oncology, Inc. Common stock
Save
4.80B
Market cap
–
Current P/E
–
Forward P/E
CGON chart
1M
3M
1Y
5Y
Loading chart...
Fundamentals
Gross margin | -15.02% |
Operating margin | -4722.13% |
Pretax margin | -3985.02% |
Net margin | -3985.02% |
Effective tax rate | – |
ROA | -20.34% |
ROE | -22.87% |
D/E | 0.01x |
Interest coverage ratio | – |
CGON valuation
P/E | – |
P/S | 1350.55x |
P/B | 6.64x |
P/CF | -37.74x |
P/FCF | -41.19x |
P/OCF | -37.74x |
PEG | 21.20x |
EV multiple | -32.77x |
About
CG Oncology Inc is a clinical biopharmaceutical company focused on developing and commercializing a potential backbone bladder-sparing therapeutic for patients afflicted with bladder cancer.
Similar securities
Based on sector and market capitalization
Report issue